Conversely, Kumar et al. [60] showed a reduction in Foxp3+ Treg cells in both treated and untreated CeD patient’s PBMCs when compared to controls, with similar values between untreated and treated CeD [60]. The gene discussed is FOXP3; the disease is cranioectodermal dysplasia.